Moody's: Pharma outlook stable for next 12-18 months
source link: https://finance.yahoo.com/news/moodys-pharma-outlook-stable-for-next-12-18-months-but-with-caveats-181706209.html
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
Moody's: Pharma outlook stable for next 12-18 months, but with caveats
Moody's predicts a stable outlook for the pharmaceutical industry for the next year or so, even as it battles a number of headwinds.
First, the headwinds.
The drug industry, for example, is fighting back on drug pricing negotiations with Medicare. And some of the largest companies are facing pressure on their pipelines with patents expiring for some major brands in the next few years.
Moody's senior vice president for investor services, Michael Levesque, said as much Thursday.
"Pressure points will rise in 2025 and beyond, including a steeper patent cliff, drug pricing changes in the US Inflation Reduction Act, and proposed changes to European drug regulations," he wrote in a note to investors.
But Medicare and patents aren't the only battles. Pushback from the US Federal Trade Commission is another hurdle for the industry. One recent example is the FTC's efforts, joined by several states, to stop Amgen's (AMGN) potential $28 billion acquisition of Horizon Therapeutics.
That is a problem for an industry flush with cash, eager to engage in M&A that would help thwart Medicare efforts to control pricing. At last tally, in December 2022, the 15 largest investment-grade issuers were sitting on $164 billion, Levesque said.
But there's optimism too: Blockbuster drug sales and the hot new obesity drug market will help drive earnings growth.
"Rising sales of...drugs treating cancer, autoimmune diseases, and diabetes/obesity will drive 2-4% earnings growth," Levesque said.
Another bright spot, albeit smaller, is the uptick in COVID vaccines for the fall and winter, which will mostly benefit Pfizer (PFE), he said.
"We could change our outlook to positive if we expect annual EBITDA growth above 4% over a future 12-18 months period. This could occur if there are material new product launches in under-treated diseases, if the impact of patent exposures declines, or if treatments or vaccines for COVID-19 see rising rather than weakening demand," Levesque wrote.
- Investor's Business Daily
Is Pfizer Stock A Buy Or A Sell On New Challenges In Obesity Treatment?
Is Pfizer stock a buy or a sell after scrapping its once-daily pill for obesity treatment? Is PFE stock a buy or a sell right now?
3h ago - Zacks
Biotech Stock Roundup: SRPT's DMD Therapy Approval, ICPT's Setback & More Updates
Regulatory updates from Sarepta (SRPT) and Intercept (ICPT) are in focus in the biotech sector.
9h ago - Yahoo Finance
Coinbase says SEC 'lacks authority' to bring lawsuit
The question of what constitutes a security will be key to a wide-ranging legal campaign by the SEC to crack down on the cryptocurrency industry.
4h ago - Yahoo Finance
Republicans tout rural broadband — even if they voted against it
Some Republicans this week applauded the money for rural high-speed internet headed to their states.
6h ago - Yahoo Finance
Expect lower gas prices this July 4th weekend
Expect record travelers to hit the roads this 4th of July weekend. Some good news though — gas prices will cost about $1.30 less per gallon this year, than last.
4h ago - Benzinga
Sigilon Therapeutics Shares Are Shooting Higher Today - What's Going On
Sigilon Therapeutics Inc (NASDAQ: SGTX) shares are skyrocketing after Eli Lilly And Co (NYSE: LLY) agreed to acquire the company for a purchase price of $14.92 per share in cash (an aggregate of approximately $34.6 million). Sigilon is also entitled to one non-tradeable contingent value right ("CVR") per share to receive up to an additional $111.64 per share in cash, for a total potential consideration of up to $126.56 per share in cash without interest (an aggregate of up to approximately $309.
6h ago - TipRanks
Goldman Sachs Says Attractive Valuations Make Small-Cap Stocks Appealing; Here Are 2 ‘Strong Buy’ Names With Solid Upside Potential
The S&P 500 is up by 14% year-to-date but it has not gone unnoticed that the robust performance has been driven by strong displays from the tech mega-caps. According to Goldman Sachs strategist Lily Calcagnini, there are better investment opportunities right now further down the food chain. “Small stocks trade at a valuation discount relative to large caps, suggesting now is an attractive entry point for investors with multi-year investing time horizons,” Calcagnini explained. “Even within the l
21h ago - Yahoo Finance
Why TikTok's new e-commerce attempt is risky bet
The social media giant recently confirmed that it is testing a new in-app shopping feature called Trendy Beat in the United Kingdom after becoming the first app to surpass $1 billion in consumer spending in a single quarter.
4h ago - Yahoo Finance
The US economy is a lot stronger than Wall Street thought
A first quarter upward GDP revision is just one of many economic indicators projecting a healthier economy than experts had expected.
5h ago - Benzinga
'So Unprecedented': Kevin O'Leary Says Bud Light Is The Gift That Keeps On Giving, Plans To Teach Its 25% Market Share Collapse To College Students
Bud Light is in the headlines again. The CEO of Anheuser-Busch InBev (NYSE: BUD), the multinational brewing company behind Bud Light, is reportedly planning to go on a tour this summer to listen to consumers. But “Shark Tank” star Kevin O’Leary, also known as Mr. Wonderful, doesn’t believe it will turn things around. “I don’t think that’s going to work,” O’Leary said in a recent interview with Fox Business. “He’s going to get an earful, there’s no question about it. The problem with that tour an
1d ago - Benzinga
Ark Invest's Cathie Wood Is Betting Big On AI With These 4 Stocks — Including One That Could Skyrocket 670%
Ark Invest's Cathie Wood is known for investing in disruptive innovation. The super investor has placed big bets on artificial intelligence (AI), which is widely regarded as one of the most disruptive and transformative technologies today. Speaking of AI stocks, it's hard to ignore what Nvidia Corp. (NASDAQ:NVDA) has been doing. Shares of the chipmaking giant have surged 187% so far this year, and the company crossed $1 trillion in valuation. Ark Invest's flagship fund Ark Innovation ETF (NYSE:A
2h ago - Investor's Business Daily
GE Stock Rallies 64% Ahead Of Its Huge Aerospace Play. What's In Store For Investors.
General Electric is in the final phase of slimming from flabby conglomerate to the focused GE Aerospace. Could anything trip up GE stock?
4h ago - TipRanks
Too Cheap to Ignore: 2 Dividend Stocks Under $10 With at Least 11% Dividend Yield — Analysts Say ‘Buy’
Every investor seeks to reap the rewards of their stocks; otherwise, they wouldn’t be involved in the markets. However, discovering the ideal investment, one that will yield profits, can prove to be a challenge, particularly in today’s market environment. To ensure solid returns, investors can follow two straightforward strategies. The first is to buy low and sell high. That is, find a cheap stock with sound fundamentals and good prospects for growth – and buy in to take advantage of the growth
8h ago - Zacks
Plug Power, Inc. (PLUG) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Plug Power (PLUG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
9h ago - Barrons.com
Virgin Galactic Takes First Customers to Edge of Space. Why the Stock Is Down.
The flight, dubbed Galactic 01, marks the start of commercial service for the space tourism pioneer after a series of delays.
4h ago - Zacks
Ford Motor Company (F) Upgraded to Buy: Here's What You Should Know
Ford Motor Company (F) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
1d ago - Zacks
Is Most-Watched Stock NIO Inc. (NIO) Worth Betting on Now?
NIO Inc. (NIO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
1d ago - Benzinga
How To Earn $500 A Month From AT&T Stock
AT&T Inc. (NYSE:T) CFO Pascal Desroches spoke last week at the Bank of America C-Suite Technology, Media and Telecommunications Conference, providing updates on the telecom giant’s performance and strategies. What Happened: Desroches reiterated AT&T's full-year free cash flow target of $16 billion or more for 2023. He also mentioned the company’s projected second-quarter free cash flow, expected to range between $3.5 to $4.0 billion. AT&T is tracking to just over 300,000 postpaid phone net addit
8h ago - Zacks
3 Highly Ranked Chip Stocks to Buy Outside of Nvidia (NVDA)
For those looking for options outside of the Nvidia bandwagon, let's take a look at three alternative chip stocks that also covet a Zacks Rank #1 (Strong Buy).
1d ago - Investor's Business Daily
Sigilon Therapeutics Scores Eli Lilly Buyout And Skyrockets More Than 400%
Eli Lilly said Thursday it will buy its diabetes treatment partner, Sigilon Therapeutics, and the biotech stock skyrocketed.
2h ago - Zacks
The Zacks Analyst Blog Highlights Kinder Morgan, MPLX and The Williams Companies
Kinder Morgan, MPLX and The Williams Companies are included in this Analyst Blog.
13h ago - Reuters
Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments
A major provider of diabetes drugs and insulin, Lilly owned nearly 8.44% stake in Sigilon as of March 27. Sigilon shareholders will get an additional $111.64 per share if they achieve certain developmental and regulatory milestones, Lilly said. Shares of Sigilion soared more than eightfold in premarket trading to $34.48.The deal, which is expected to close in the third quarter of 2023, would give Lilly access to Sigilon's proprietary cell therapy candidate being developed to treat type 1 diabetes.
10h ago - Business Insider
Forget FAANG and GAMMA, the 'Magnificent 7' tech stocks - including Tesla and Nvidia - now dominate the market
Investors have piled into Big Tech this year, thanks to the rise of AI and the expectation that the Federal Reserve will soon cut interest rates.
2h ago - Barrons.com
Cathie Wood’s ARK Sold More Tesla Stock, Buys AMD
STOCKSTOWATCHTODAY BLOG Cathie Wood’s ARK Invest continues to unload Tesla stock after the electric-vehicle pioneer’s significant rally this year. The asset manager disclosed on its website that it had sold a combined 28,386 Tesla shares on Wednesday.
7h ago - Zacks
All You Need to Know About Annaly (NLY) Rating Upgrade to Buy
Annaly (NLY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
1d ago - Zacks
Norwegian Cruise Line (NCLH) Surges 7.6%: Is This an Indication of Further Gains?
Norwegian Cruise Line (NCLH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
7h ago - Investor's Business Daily
Is Moderna Stock A Buy As It Doubles Down On Its Cancer Vaccine Efforts?
Is Moderna stock a buy after unveiling new results for its Merck-partnered cancer vaccine? Is MRNA stock a buy today?
3h ago - SmartAsset
Earn Over $145k? You May Have to Pay Taxes on Your Catch-Up Contributions
Catch-up contributions are about to change. Starting in 2024, some workers who make catch-up contributions to employer-sponsored retirement plans, like a 401(k), will have to put this money in a Roth account. This means that they cannot deduct these contributions from … Continue reading → The post Earn Over $145k? You May Have to Pay Taxes on Your Catch-Up Contributions appeared first on SmartAsset Blog.
12h ago - SmartAsset
Interest Rates Are High. But Should I Still Hold Cash in My Portfolio?
With some bank CDs paying more than a 5% APY and some savings and money market accounts yielding around that figure too (as of June 2023), no one can blame investors if they've become tempted to keep a healthy chunk … Continue reading → The post Even With High Interest Rates, Should You Hold Cash in Your Portfolio? appeared first on SmartAsset Blog.
9h ago - Investor's Business Daily
Blacklisted 'Woke' Companies Gain $832 Billion During Boycotts
Consumers who don't like a company's politics can boycott their products. But ETFs trying to cash in struggle to beat the S&P 500.
10h ago - AP Finance
3 charged in insider trading case related to taking Trump media firm public, accused of making $22M
Three Florida men were charged Thursday with making more than $22 million through illegal insider trading before the public announcement that an acquisition firm was going to take former President Donald Trump's media company public. The charges were outlined in an indictment unsealed in New York that did not in any way implicate Trump or Trump Media & Technology Group, which owns his Truth Social platform. The charges make it less likely that Trump Media will be able to pocket the $1.3 billion promised upon completion of a merger with the acquisition firm.
7h ago - Barrons.com
Moderna and 7 More Stocks That Can Beat Big Tech in the Second Half
Big Tech is having its best start to the year ever. But a different group may thrive in the second half.
9h ago - Zacks
BlackBerry (BB) Q1 Earnings & Revenues Beat Estimates, Up Y/Y
BlackBerry's (BB) performance benefits from solid momentum in the QNX software platform and secular growth trends.
10h ago - Zacks
Greenbrier Companies (GBX) Q3 Earnings and Revenues Top Estimates
Greenbrier (GBX) delivered earnings and revenue surprises of 70% and 10.06%, respectively, for the quarter ended May 2023. Do the numbers hold clues to what lies ahead for the stock?
11h ago - Yahoo Finance
All 23 banks survive Fed's 2023 stress test
The big banks tested by the Federal Reserve showed they could withstand a severe global recession and hundreds of billions in losses.
1d ago - Business Insider
A flood of housing inventory will hit the market once mortgage rates hit this key level, Compass CEO says
Inventory has been tight recently, as 70% of homeowners are locked into mortgage rates below 4%, leaving many hesitant to sell.
21h ago - Benzinga
What's Going On With Alibaba Stock Thursday
Alibaba Group Holding Limited (NYSE: BABA) and Chinese peer stocks are trading lower Thursday after a government report exhibited manufacturing in mainland China contracted for a third month in June, underlining concerns about the lack of significant policy stimulus. Prices also weakened as prominent global central bankers said more tightening might be needed to contain inflation, SCMP reports. Chinese ETFs, including IShares China Large-Cap ETF (NYSE: FXI) and KraneShares Trust KraneShares CSI
5h ago - Zacks
Enphase (ENPH) Unveils New IQ8 Microinverters in Germany
Enphase (ENPH) launches its new state-of-the-art microinverter from the IQ8 family for customers in Germany.
9h ago - AP Finance
Microsoft makes final case for Activision Blizzard deal as federal judge decides whether to block it
The fate of what could be the priciest merger in tech industry history will soon be in the hands of a federal judge who must decide whether to stop Microsoft from closing its deal to buy video game company Activision Blizzard. Federal antitrust enforcers have sued to block the $69 billion acquisition that they say will harm competition between Microsoft and gaming industry competitors such as Sony and Nintendo. The Federal Trade Commission, which enforces antitrust laws, has asked U.S. District Judge Jacqueline Scott Corley to issue an injunction that would temporarily block Microsoft and Activision from closing the deal before the FTC's in-house judge can review it in an August trial.
3h ago - Investor's Business Daily
Dow Jones Rises After Surprise Drop In Jobless Claims, Strong GDP; Cathie Wood Sells $7 Million In Tesla Stock
The Dow Jones rose Thursday after initial jobless claims and Q1 GDP data. Cathie Wood sold more than $7 million in Tesla stock.
8h ago
Recommend
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK